Triple-negative breast cancer: recent treatment advances [version 1; peer review: 2 approved]
Triple-negative breast cancer (TNBC) is a breast cancer subtype renowned for its capacity to affect younger women, metastasise early despite optimal adjuvant treatment and carry a poor prognosis. Neoadjuvant therapy has focused on combinations of systemic agents to optimise pathological complete res...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-08-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-1342/v1 |